Gene Expression Profiling of Paraffin-Embedded Primary Melanoma Using the DASL Assay Identifies Increased Osteopontin Expression as Predictive of Reduced Relapse-Free Survival

C. Conway, A. Mitra, R. Jewell, J. Randerson-Moor, S. Lobo, J. Nsengimana, S. Edward, D. S. Sanders, M. Cook, B. Powell, A. Boon, F. Elliott, F. de Kort, M. A. Knowles, D. T. Bishop, J. Newton-Bishop

    Research output: Contribution to journalArticle

    78 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)6939
    JournalClinical Cancer Research
    Volume15
    Issue number22
    DOIs
    Publication statusPublished - 2009

    Cite this

    Conway, C., Mitra, A., Jewell, R., Randerson-Moor, J., Lobo, S., Nsengimana, J., Edward, S., Sanders, D. S., Cook, M., Powell, B., Boon, A., Elliott, F., de Kort, F., Knowles, M. A., Bishop, D. T., & Newton-Bishop, J. (2009). Gene Expression Profiling of Paraffin-Embedded Primary Melanoma Using the DASL Assay Identifies Increased Osteopontin Expression as Predictive of Reduced Relapse-Free Survival. Clinical Cancer Research, 15(22), 6939. https://doi.org/10.1158/1078-0432.CCR-09-1631